CABA
Price
$2.79
Change
-$0.22 (-7.31%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
454.11M
50 days until earnings call
Intraday BUY SELL Signals
CGEM
Price
$13.55
Change
-$0.06 (-0.44%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
831.83M
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CABA vs CGEM

Header iconCABA vs CGEM Comparison
Open Charts CABA vs CGEMBanner chart's image
CABA vs CGEM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CABA vs. CGEM commentary
Jun 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and CGEM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 17, 2026
Stock price -- (CABA: $2.79 vs. CGEM: $13.61)
Brand notoriety: CABA and CGEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 158% vs. CGEM: 175%
Market capitalization -- CABA: $454.11M vs. CGEM: $831.83M
CABA [@Biotechnology] is valued at $454.11M. CGEM’s [@Biotechnology] market capitalization is $831.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $115.02B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 0 FA rating(s) are green whileCGEM’s FA Score has 1 green FA rating(s).

  • CABA’s FA Score: 0 green, 5 red.
  • CGEM’s FA Score: 1 green, 4 red.
According to our system of comparison, CABA is a better buy in the long-term than CGEM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 4 TA indicator(s) are bullish while CGEM’s TA Score has 5 bullish TA indicator(s).

  • CABA’s TA Score: 4 bullish, 6 bearish.
  • CGEM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than CABA.

Price Growth

CABA (@Biotechnology) experienced а -13.51% price change this week, while CGEM (@Biotechnology) price change was +2.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.66%. For the same industry, the average monthly price growth was -1.63%, and the average quarterly price growth was +2020.83%.

Reported Earning Dates

CABA is expected to report earnings on Aug 06, 2026.

CGEM is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+0.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($832M) has a higher market cap than CABA($454M). CGEM YTD gains are higher at: 30.773 vs. CABA (27.169). CABA has higher annual earnings (EBITDA): -171.58M vs. CGEM (-240.04M). CGEM has more cash in the bank: 352M vs. CABA (117M). CGEM has less debt than CABA: CGEM (2.38M) vs CABA (26.4M). CABA (0) and CGEM (0) have equivalent revenues.
CABACGEMCABA / CGEM
Capitalization454M832M55%
EBITDA-171.58M-240.04M71%
Gain YTD27.16930.77388%
P/E RatioN/AN/A-
Revenue00-
Total Cash117M352M33%
Total Debt26.4M2.38M1,108%
FUNDAMENTALS RATINGS
CABA: Fundamental Ratings
CABA
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABACGEM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
89%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signal:
Gain/Loss:
CGEM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSCHX23.69N/A
N/A
Nuveen Quant Small Cap Equity I
MRFOX34.95N/A
N/A
Marshfield Concentrated Opportunity
GABEX5.24N/A
N/A
Gabelli Equity Income AAA
BLRCX13.12N/A
N/A
Brookfield Global Listed Real Estate C
RNWAX103.21-0.46
-0.44%
American Funds New World R1

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with VIR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-0.55%
VIR - CGEM
49%
Loosely correlated
N/A
PCVX - CGEM
44%
Loosely correlated
-0.54%
NRIX - CGEM
44%
Loosely correlated
+0.18%
RLAY - CGEM
43%
Loosely correlated
+0.60%
XNCR - CGEM
43%
Loosely correlated
-0.08%
More